Related Experiment Videos
Suppression by the cyclohexanetrione Ro 31-0521 of retinoic acid-induced teratogenicity
Experientia
|January 15, 1986
Abstract:
The cyclohexanetrione Ro 31-0521, which stimulates prostaglandin synthesis, inhibited retinoic acid-induced cartilage degradation in vitro and suppressed the congenital forelimb malformations in rats treated with retinoic acid on day 13 of gestation in a dose-dependent manner.
Insights
The compound Ro 31-0521, a cyclohexanetrione, prevents cartilage breakdown and limb malformations caused by retinoic acid. This suggests a potential therapeutic role in developmental abnormalities.
Area of Science:
- Biochemistry
- Developmental Biology
- Pharmacology
Background:
- Retinoic acid is crucial for development but can cause birth defects.
- Cartilage degradation is a pathological process implicated in various conditions.
Purpose of the Study:
- To investigate the effects of cyclohexanetrione Ro 31-0521 on retinoic acid-induced biological processes.
- To evaluate Ro 31-0521's potential to counteract cartilage degradation and limb malformations.
Main Methods:
- In vitro assays to assess cartilage degradation.
- In vivo studies using pregnant rats treated with retinoic acid.
- Dose-response analysis of Ro 31-0521 administration.
Main Results:
- Ro 31-0521 inhibited retinoic acid-induced cartilage degradation in vitro.
- Ro 31-0521 dose-dependently suppressed congenital forelimb malformations in rats exposed to retinoic acid.
- The compound stimulates prostaglandin synthesis.
Conclusions:
- Cyclohexanetrione Ro 31-0521 demonstrates protective effects against retinoic acid-induced developmental toxicity.
- Ro 31-0521 shows potential as a therapeutic agent for preventing cartilage damage and birth defects.